Carib A. Oquendo

Array ( [id] => 11561737 [patent_doc_number] => 09624309 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-04-18 [patent_title] => 'Monospecific and multispecific antibodies and method of use' [patent_app_type] => utility [patent_app_number] => 12/671942 [patent_app_country] => US [patent_app_date] => 2008-08-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 14066 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12671942 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5575929 [patent_doc_number] => 20090143291 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-06-04 [patent_title] => 'TUMOR ANTIGEN BASED ON PRODUCTS OF THE TUMOR SUPPRESSOR GENE WT1' [patent_app_type] => utility [patent_app_number] => 12/181938 [patent_app_country] => US [patent_app_date] => 2008-07-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 4931 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0143/20090143291.pdf [firstpage_image] =>[orig_patent_app_number] => 12181938 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4551 [patent_doc_number] => 07811986 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-10-12 [patent_title] => 'Genes from the 20Q13 amplicon and their uses' [patent_app_type] => utility [patent_app_number] => 12/177608 [patent_app_country] => US [patent_app_date] => 2008-07-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 6 [patent_no_of_words] => 18453 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/811/07811986.pdf [firstpage_image] =>[orig_patent_app_number] => 12177608 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9099114 [patent_doc_number] => 08562986 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-10-22 [patent_title] => 'Engineered anti-alpha V-integrin hybrid antibodies' [patent_app_type] => utility [patent_app_number] => 12/669408 [patent_app_country] => US [patent_app_date] => 2008-07-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 32 [patent_no_of_words] => 17716 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12669408 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8554704 [patent_doc_number] => 08329173 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-12-11 [patent_title] => 'Antibodies inhibiting c-Met dimerization and uses thereof' [patent_app_type] => utility [patent_app_number] => 12/440571 [patent_app_country] => US [patent_app_date] => 2008-07-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 72 [patent_figures_cnt] => 108 [patent_no_of_words] => 33210 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12440571 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5508026 [patent_doc_number] => 20090081233 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-26 [patent_title] => 'Ligands that have binding specificity for VEGF and/or EGFR and methods of use therefor' [patent_app_type] => utility [patent_app_number] => 12/217884 [patent_app_country] => US [patent_app_date] => 2008-07-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 69 [patent_figures_cnt] => 69 [patent_no_of_words] => 59412 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0081/20090081233.pdf [firstpage_image] =>[orig_patent_app_number] => 12217884 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4859014 [patent_doc_number] => 20080267864 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-30 [patent_title] => 'Cancerous disease modifying antibodies' [patent_app_type] => utility [patent_app_number] => 12/217148 [patent_app_country] => US [patent_app_date] => 2008-07-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 19041 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0267/20080267864.pdf [firstpage_image] =>[orig_patent_app_number] => 12217148 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6411240 [patent_doc_number] => 20100166652 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-01 [patent_title] => 'Laminin receptor 1 precursor protein (37LRP) epitope delineated by an hepatocellular carcinoma specific antibody' [patent_app_type] => utility [patent_app_number] => 12/217191 [patent_app_country] => US [patent_app_date] => 2008-07-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 15885 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0166/20100166652.pdf [firstpage_image] =>[orig_patent_app_number] => 12217191 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5278584 [patent_doc_number] => 20090130716 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-05-21 [patent_title] => 'Rationally designed antibodies' [patent_app_type] => utility [patent_app_number] => 12/217216 [patent_app_country] => US [patent_app_date] => 2008-07-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 37 [patent_figures_cnt] => 37 [patent_no_of_words] => 23515 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0130/20090130716.pdf [firstpage_image] =>[orig_patent_app_number] => 12217216 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4886403 [patent_doc_number] => 20080260735 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-23 [patent_title] => 'Transfer request (37 CFR 1.821(e)) humanised antibodies to the epidermal growth factor receptor' [patent_app_type] => utility [patent_app_number] => 12/155986 [patent_app_country] => US [patent_app_date] => 2008-06-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 9116 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0260/20080260735.pdf [firstpage_image] =>[orig_patent_app_number] => 12155986 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6125357 [patent_doc_number] => 20110086019 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-04-14 [patent_title] => 'POLYPEPTIDES, ANTIBODY VARIABLE DOMAINS AND ANTAGONISTSMETHODS FOR' [patent_app_type] => utility [patent_app_number] => 12/663509 [patent_app_country] => US [patent_app_date] => 2008-06-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 91 [patent_figures_cnt] => 91 [patent_no_of_words] => 57431 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0086/20110086019.pdf [firstpage_image] =>[orig_patent_app_number] => 12663509 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6095308 [patent_doc_number] => 20110002929 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-06 [patent_title] => 'AMINO ACID SEQUENCES DIRECTED AGAINST RANK-L AND POLYPEPTIDES COMPRISING THE SAME FOR THE TREATMENT OF BONE DISEASES AND DISORDERS' [patent_app_type] => utility [patent_app_number] => 12/599892 [patent_app_country] => US [patent_app_date] => 2008-05-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 30 [patent_no_of_words] => 109595 [patent_no_of_claims] => 262 [patent_no_of_ind_claims] => 166 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0002/20110002929.pdf [firstpage_image] =>[orig_patent_app_number] => 12599892 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5569351 [patent_doc_number] => 20090252729 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-08 [patent_title] => 'Single-chain Fc (scFc) regions, binding polypeptides comprising same, and methods related thereto' [patent_app_type] => utility [patent_app_number] => 12/152622 [patent_app_country] => US [patent_app_date] => 2008-05-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 73 [patent_figures_cnt] => 73 [patent_no_of_words] => 60405 [patent_no_of_claims] => 111 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0252/20090252729.pdf [firstpage_image] =>[orig_patent_app_number] => 12152622 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4676965 [patent_doc_number] => 20080214596 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-04 [patent_title] => 'BIOMARKERS FOR SENSITIVITY OF PROLIFERATIVE DISEASES TO MTOR INHIBITORS' [patent_app_type] => utility [patent_app_number] => 12/119640 [patent_app_country] => US [patent_app_date] => 2008-05-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2651 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0214/20080214596.pdf [firstpage_image] =>[orig_patent_app_number] => 12119640 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6038400 [patent_doc_number] => 20110091449 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-04-21 [patent_title] => 'Isolation of Anti-Desmoglein 1 Antibodies by Phage Display of Pemphigus Foliaceus Autoantibodies' [patent_app_type] => utility [patent_app_number] => 12/666265 [patent_app_country] => US [patent_app_date] => 2008-05-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 32 [patent_no_of_words] => 22682 [patent_no_of_claims] => 48 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0091/20110091449.pdf [firstpage_image] =>[orig_patent_app_number] => 12666265 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7697115 [patent_doc_number] => 20110229475 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-22 [patent_title] => 'NOVEL COMPOUNDS' [patent_app_type] => utility [patent_app_number] => 12/596262 [patent_app_country] => US [patent_app_date] => 2008-04-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 20830 [patent_no_of_claims] => 50 [patent_no_of_ind_claims] => 20 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0229/20110229475.pdf [firstpage_image] =>[orig_patent_app_number] => 12596262 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5270944 [patent_doc_number] => 20090074720 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-19 [patent_title] => 'METHODS FOR DECREASING IMMUNE RESPONSE AND TREATING IMMUNE CONDITIONS' [patent_app_type] => utility [patent_app_number] => 12/098419 [patent_app_country] => US [patent_app_date] => 2008-04-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 24809 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0074/20090074720.pdf [firstpage_image] =>[orig_patent_app_number] => 12098419 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5580521 [patent_doc_number] => 20090175867 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-09 [patent_title] => 'Single-Chain Multivalent Binding Proteins with Effector Function' [patent_app_type] => utility [patent_app_number] => 12/041590 [patent_app_country] => US [patent_app_date] => 2008-03-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 59 [patent_figures_cnt] => 59 [patent_no_of_words] => 69994 [patent_no_of_claims] => 81 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0175/20090175867.pdf [firstpage_image] =>[orig_patent_app_number] => 12041590 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6248767 [patent_doc_number] => 20100137221 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-03 [patent_title] => 'PEPTIDES THAT INTERACT WITH TOPOISOMERASE I AND METHODS THEREOF' [patent_app_type] => utility [patent_app_number] => 12/525216 [patent_app_country] => US [patent_app_date] => 2008-02-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 17556 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0137/20100137221.pdf [firstpage_image] =>[orig_patent_app_number] => 12525216 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5495355 [patent_doc_number] => 20090263383 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-22 [patent_title] => 'Antibodies to angiogenesis inhibiting domains of CD148' [patent_app_type] => utility [patent_app_number] => 12/072737 [patent_app_country] => US [patent_app_date] => 2008-02-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 15297 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0263/20090263383.pdf [firstpage_image] =>[orig_patent_app_number] => 12072737 [rel_patent_id] =>[rel_patent_doc_number] =>)